Chromosomal landing pads and related uses
AssigneeThe Scripps Research Institute
InventorsVincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Scripps Research Institute
InventorsVincent P. Mauro, Wei Zhou, Bruce Cunningham, Gerald M. Edelman
Estimating the term…
Provided herein are methods for stable integration and/or expression of one or more recombinant polynucleotides in a host cell. The recombinant polynucleotides are typically integrated into the host genome at some native chromosomal integration sites. The integration can be mediated by homologous recombination or by using a hybrid recombinase targeting the specific chromosomal locations. The native chromosomal integration sites in the host cells, which support stable integration and strong transcription activities of foreign genes, are present within or adjacent to specific genes in the CHO genome, ankyrin 2 gene (Ank2), cleavage and polyadenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene. Also provided are methods and nucleic acid molecules for inserting site-specific recombination sequences (chromosomal landing pads) into these specific chromosomal locations, engineered host cells containing chromosomal landing pads, methods and compositions (e.g., kits) therefore.
A method for stable integration and expression of a heterologous polynucleotide in a host cell, comprising inserting the heterologous polynucleotide into the genome of the host cell at a native chromosomal site located within or adjacent to a gene selected from the group consisting of ankyrin 2 gene (Ank2), cleavage and polyadenylation specific factor 4 gene (Cpsf4), C-Mos gene, and Nephrocystin-1/Mal gene.
A recombinant polynucleotide for stably integrating a heterologous polynucleotide sequence into the genome of a mammalian cell, comprising:
An engineered mammalian cell, comprising a heterologous polynucleotide which is stably integrated into its genome at one or more native chromosomal insertion sites located within or adjacent to a gene selected from the group consisting of ankyrin 2 gene (Ank2), cleavage and polyadenylation specific factor 4 gene (Cpsf4), C-Mos gene and Nephrocystin-1/Mal gene.
A method for stably integrating a heterologous polynucleotide into the genome of a mammalian cell, comprising:
Dependencies are inferred from the claim text.